Low dose nivolumab in metastatic mucosal melanoma: a case report

被引：0

作者：

Meraz-Brenez, Andres ^{[1
]}

Navarrete-Reyes, Ana P. ^{[2
]}

Ignacio-Alvarez, Eleazar ^{[3
]}

Ramirez-Anguiano, Georgina J. ^{[4
]}

Verduzco-Aguirre, Haydee C. ^{[1
]}

机构：

[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hematooncol, Mexico City, DF, Mexico

[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Geriatr Serv, Mexico City, DF, Mexico

[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Nucl Med Serv, Mexico City, DF, Mexico

[4] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Otorhinolaryngol Serv, Mexico City, DF, Mexico

来源：

GACETA MEXICANA DE ONCOLOGIA | 2023年 / 22卷 / 03期

关键词：

Melanoma; Nivolumab; Geriatric oncology; Case report; Financial toxicity; FINANCIAL TOXICITY; CANCER; POPULATION; OUTCOMES;

D O I：

10.24875/j.gamo.23000030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We present the case of a 77-year-old man with metastatic mucosal melanoma, unable to afford standard doses of immunotherapy, who was treated with nivolumab at a lower dose of 0.5 mg/kg every 2 weeks. Drug activity was demonstrated through both objective tumor response and an immune-related adverse event. This suggests that a lower dose of nivolumab could be a viable alternative for patients with advanced mucosal melanoma at a high risk of treatment-related financial toxicity. Further research is needed to evaluate the efficacy of lower doses of immunotherapy, including its impact on long term outcomes.

引用

页码：140 / 145

页数：6

共 50 条

[31] Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
Yang, Shih-Hung
Lee, Jen-Chieh
Chen, Bang-Bin
Kuo, Sung-Hsin
Hsu, Chiun
Bai, Li-Yuan
FRONTIERS IN IMMUNOLOGY, 2022, 13
[32] Therapeutic Responses to Combination Nivolumab and Temozolomide as Salvage Therapy for Metastatic Melanoma: A Case Series
Goodman, Rachel S.
Jung, Seungyeon
Quintos, Jessica
Johnson, Douglas B.
ONCOLOGIST, 2023, 28 (09) : E839 - E842
[33] Metastatic melanoma of the gallbladder: A case report and systematic review
Geng, Zhidan
Tang, Congyu
Chen, Jianfei
Luo, Rongkui
Yu, Qing
Yuan, Haixia
JOURNAL OF CLINICAL ULTRASOUND, 2024, 52 (08) : 1113 - 1120
[34] Laparoscopic pancreaticoduodenectomy for metastatic pancreatic melanoma A case report
Liu, Xueqing
Feng, Feng
Wang, Tianyang
Qin, Jianzhang
Yin, Xiangyan
Meng, Guiqing
Yan, Changqing
Xing, Zhongqiang
Duan, Jiayue
Liu, Chen
Liu, Jianhua
MEDICINE, 2018, 97 (44)
[35] Metastatic melanoma of the tongue: a case report with immunohistochemical profile
Alves, Monica Ghislaine O.
Chagas, Luciene R.
Carvalho, Yasmin R.
Cabral, Luiz A. G.
Coletta, Ricardo D.
Almeida, Janete D.
GERODONTOLOGY, 2014, 31 (04) : 314 - 319
[36] Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma
Mullally, W. J.
Cooke, F. J.
Crosbie, I. M.
Kumar, S.
Abernethy, V. E.
Jordan, E. J.
O'Connor, M.
Horgan, A. M.
Landers, R.
Naidoo, J.
Calvert, P. M.
FRONTIERS IN IMMUNOLOGY, 2022, 13
[37] Intraventricular metastatic melanoma: A case report and review of the literature
Bernstock, Joshua D.
Chagoya, Gustavo
Elsayed, Galal A.
Fox, Brandon M.
Mir, Nabiel
Gupta, Saksham
Chua, Melissa
Atchley, Travis J.
Lobbous, Mina
Sotoudeh, Houman
Hackney, James
Friedman, Gregory K.
Harrigan, Mark R.
CLINICAL CASE REPORTS, 2020, 8 (09): : 1757 - 1764
[38] A case of pure red cell aplasia during nivolumab therapy for cardiac metastatic melanoma
Yuki, Akihiko
Takenouchi, Tatsuya
Takatsuka, Sumiko
Ishiguro, Takuro
MELANOMA RESEARCH, 2017, 27 (06) : 635 - 637
[39] Nivolumab plus relatlimab for the treatment of unresectable or metastatic melanoma
Kosela-Paterczyk, Hanna
Rutkowski, Piotr
EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (05) : 383 - 388
[40] Aspiration cytology of liver abscess uncovering metastatic rectal mucosal melanoma-A case report
Ng, Joanna K. M.
Leung, Howard H. W.
Li, Joshua J. X.
CYTOPATHOLOGY, 2024, 35 (01) : 163 - 166

← 1 2 3 4 5 →